ArticleWorld journal of gastrointestinal oncology2019

TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer.

Anastasios Ntavatzikos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.